AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36375487 — intervention group
Group type: COMPARATOR
Intervention: Control (Proton Pump Inhibitor - Lansoprazole)
Number of subjects: 33
Study 32461325 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 positive cases with anosmia or dysgeusia or both
Number of subjects: 134
Study 32461325 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of myalgia
Number of subjects: 134
Study 32461325 — intervention group
Group type: EXPERIMENTAL
Intervention: Blurred vision
Number of subjects: 134
Study 32461325 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest pain
Number of subjects: 134
Study 34314240 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquablation
Number of subjects: 391
Study 34314240 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift (PUL)
Number of subjects: 391
Study 34314240 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral Water Vapor Therapy (TWVT)
Number of subjects: 391
Study 34257042 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide prophylaxis (3 mg PO daily at day +5 post‐AHCT till discharge)
Number of subjects: 257
Study 34257042 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 257
Study 34257042 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide prophylaxis
Number of subjects: 257
Study 34344218 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized medical nutrition guidance
Number of subjects: 820
Study 34344218 — intervention group
Group type: COMPARATOR
Intervention: Routine health education and nutrition guidance (Control)
Number of subjects: 820
Study 32085844 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition
Number of subjects: 825
Study 32085844 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (specifically amino acids)
Number of subjects: 825
Study 32085844 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition
Number of subjects: 825
Study 34228592 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonia inhalants (AI)
Number of subjects: 14
Study 34770243 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 69
Study 33198595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification of Interpretation (CBM-I)
Number of subjects: 45
Study 33198595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Therapy
Number of subjects: 45
Study 33198595 — intervention group
Group type: COMPARATOR
Intervention: No Treatment Control
Number of subjects: 45
Study 32105522 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure BFR-RE (30% 1RM at 80% pressure)
Number of subjects: 12
Study 32105522 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load RE (70% 1RM)
Number of subjects: 12
Study 32105522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure BFR-RE (30% 1RM at 40% pressure)
Number of subjects: 12
Study 32105522 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR-RE (both low and high pressure)
Number of subjects: 12
Study 32105522 — intervention group
Group type: EXPERIMENTAL
Intervention: Light load resistance exercise with BFR
Number of subjects: 12
Study 32105522 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR-RE
Number of subjects: 12
Study 36037830 — intervention group
Group type: EXPERIMENTAL
Intervention: Essen Stroke Risk Score (ESRS)
Number of subjects: 3441
Study 32783769 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial purified vero cell-cultured rabies vaccine (trial vaccine)
Number of subjects: 0
Study 32783769 — intervention group
Group type: COMPARATOR
Intervention: Essen group (control vaccine)
Number of subjects: 0
Study 32783769 — intervention group
Group type: EXPERIMENTAL
Intervention: Zagreb group
Number of subjects: 0
Study 32783769 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Zagreb, Essen, control)
Number of subjects: 0
Study 36085406 — intervention group
Group type: COMPARATOR
Intervention: Adult Eating Disorders program (n = 44)
Number of subjects: 21
Study 36085406 — intervention group
Group type: COMPARATOR
Intervention: Adult Intellectual Disability Mental Health program (n = 67)
Number of subjects: 21
Study 36085406 — intervention group
Group type: EXPERIMENTAL
Intervention: General Mental Health program (n = 28)
Number of subjects: 21
Study 33289450 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic valve replacement in patients with reduced LVEF
Number of subjects: 280
Study 33289450 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic valve replacement in patients with preserved LVEF
Number of subjects: 280
Study 33289450 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative early diastolic transmitral flow velocity/mitral annular tissue velocity ratio
Number of subjects: 280
Study 36174280 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct participant role (primary or secondary nurse)
Number of subjects: 193
Study 36174280 — intervention group
Group type: COMPARATOR
Intervention: Non-directed observer with no briefing or observer guide
Number of subjects: 193
Study 36174280 — intervention group
Group type: COMPARATOR
Intervention: Direct observer with an observation guide
Number of subjects: 193
Study 36174280 — intervention group
Group type: COMPARATOR
Intervention: In-scenario observer assigned to a non-clinical or other professional role
Number of subjects: 193
Study 34024173 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 × 150 mg caffeine daily for 10 days)
Number of subjects: 20
Study 34024173 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal (3 × 150 mg caffeine for 8 days then placebo)
Number of subjects: 20
Study 34024173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32195857 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal fixation
Number of subjects: 304
Study 32195857 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 304
Study 32195857 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pinning
Number of subjects: 304
Study 32195857 — intervention group
Group type: COMPARATOR
Intervention: Casting
Number of subjects: 304
Study 34289276 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir + Lamivudine + Tenofovir
Number of subjects: 464
Study 34289276 — intervention group
Group type: EXPERIMENTAL
Intervention: Darunavir + Lamivudine + Tenofovir
Number of subjects: 464
Study 34289276 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir + Lamivudine
Number of subjects: 464
Study 34289276 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine + Lamivudine
Number of subjects: 464
Study 32404908 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 40
Study 32404908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33531294 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive parental myopia (PPM) group
Number of subjects: 113
Study 33531294 — intervention group
Group type: COMPARATOR
Intervention: Negative parental myopia (NPM) group
Number of subjects: 113
Study 33531294 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall axial length of young adult myopes with parental myopia
Number of subjects: 113
Study 33531294 — intervention group
Group type: COMPARATOR
Intervention: Overall axial length of young adult myopes with non-myopic parents
Number of subjects: 113
Study 34879822 — intervention group
Group type: EXPERIMENTAL
Intervention: High mean arterial pressure (H-MAP) group (target MAP between 70 and 80 mmHg)
Number of subjects: 40
Study 34879822 — intervention group
Group type: EXPERIMENTAL
Intervention: High mean arterial pressure (H-MAP) group
Number of subjects: 40
Study 34879822 — intervention group
Group type: COMPARATOR
Intervention: Low mean arterial pressure (L-MAP) group (target MAP between 50 and 60 mmHg)
Number of subjects: 40
Study 34879822 — intervention group
Group type: COMPARATOR
Intervention: Low mean arterial pressure (L-MAP) group
Number of subjects: 40
Study 32616026 — intervention group
Group type: COMPARATOR
Intervention: Single dose of antibiotics at anesthesia induction (n = 73)
Number of subjects: 146
Study 32616026 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics at anesthesia induction and for 24 hours (n = 73)
Number of subjects: 146
Study 35130939 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurological and Psycho-affective Early Childhood Development Program
Number of subjects: 80
Study 35130939 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervened communities)
Number of subjects: 80
Study 33010188 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (6 mg/kg intravenously at week 0, followed by 90 mg subcutaneously every 8 weeks)
Number of subjects: 102
Study 33010188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 32071136 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway clearance intervention
Number of subjects: 60
Study 32071136 — intervention group
Group type: COMPARATOR
Intervention: No intervention (test-retest cohort)
Number of subjects: 60
Study 35965680 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 60
Study 35965680 — intervention group
Group type: COMPARATOR
Intervention: Routine massage
Number of subjects: 60
Study 34334314 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous oxygen pressure (tcpO2) measurement during endovascular intervention
Number of subjects: 21
Study 34334314 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic toe pressure (TP) measurement during endovascular intervention
Number of subjects: 21
Study 33777303 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban PHC workers
Number of subjects: 320
Study 33777303 — intervention group
Group type: COMPARATOR
Intervention: Rural PHC workers
Number of subjects: 320
Study 33777303 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior health workers
Number of subjects: 320
Study 33777303 — intervention group
Group type: COMPARATOR
Intervention: Junior health workers
Number of subjects: 320
Study 34284381 — intervention group
Group type: EXPERIMENTAL
Intervention: hUC-MSCs
Number of subjects: 10
Study 34409727 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition and gender behaviour change communication intervention
Number of subjects: 30
Study 32648861 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut oil (1 tablespoon or 12 mL daily)
Number of subjects: 29
Study 32648861 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil (control group)
Number of subjects: 29
Study 35201827 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath counting
Number of subjects: 278
Study 35201827 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction (cross counting)
Number of subjects: 278
Study 35201827 — intervention group
Group type: COMPARATOR
Intervention: Stress-only
Number of subjects: 278
Study 35201827 — intervention group
Group type: COMPARATOR
Intervention: No-stress
Number of subjects: 278
Study 33605656 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 262
Study 33605656 — intervention group
Group type: COMPARATOR
Intervention: No-pill control (NPC)
Number of subjects: 262
Study 33605656 — intervention group
Group type: COMPARATOR
Intervention: Double-blind placebo (DBP)
Number of subjects: 262
Study 34186504 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm in discordant trials
Number of subjects: 73
Study 34186504 — intervention group
Group type: COMPARATOR
Intervention: Control arm in concordant trials
Number of subjects: 73
Study 34186504 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis on discordant trials
Number of subjects: 73
Study 34186504 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis on concordant trials
Number of subjects: 73
Study 32453116 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Attainment Scaling (GAS) rehabilitation
Number of subjects: 120
Study 32453116 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 120
Study 33253017 — intervention group
Group type: EXPERIMENTAL
Intervention: Student-targeted contact video
Number of subjects: 163
Study 33253017 — intervention group
Group type: COMPARATOR
Intervention: MH comparison contact video
Number of subjects: 163
Study 33253017 — intervention group
Group type: COMPARATOR
Intervention: Non‐MH comparison video
Number of subjects: 163
Study 33253017 — intervention group
Group type: EXPERIMENTAL
Intervention: Student-targeted contact video among participants with preexisting psychological distress
Number of subjects: 163
Study 34626840 — intervention group
Group type: EXPERIMENTAL
Intervention: BSHAPE intervention
Number of subjects: 70
Study 32321651 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (TRPMS)
Number of subjects: 30
Study 32321651 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30
Study 37585146 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary iron intake <18 mg/day
Number of subjects: 206
Study 37585146 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary iron intake 18-27 mg/day
Number of subjects: 206
Study 37585146 — intervention group
Group type: COMPARATOR
Intervention: Dietary iron intake >27 mg/day (reference group)
Number of subjects: 206
Study 32718692 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus testosterone (TEX)
Number of subjects: 26
Study 32718692 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus placebo (PEX)
Number of subjects: 26
Study 32718692 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 26
Study 36889611 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic-dose enoxaparin
Number of subjects: 3398
Study 36889611 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose enoxaparin and therapeutic-dose apixaban
Number of subjects: 3398
Study 36889611 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose anticoagulation (therapeutic-dose enoxaparin and therapeutic-dose apixaban)
Number of subjects: 3398
Study 33096121 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinative exercise (CE)
Number of subjects: 135
Study 33096121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CVE)
Number of subjects: 135
Study 33096121 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 135
Study 35049134 — intervention group
Group type: EXPERIMENTAL
Intervention: SENSory relearning and task-specific training
Number of subjects: 27
Study 35049134 — intervention group
Group type: COMPARATOR
Intervention: Task-specific training only (Control Group)
Number of subjects: 27
Study 33611431 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy plus cTACE (arm A)
Number of subjects: 168
Study 33611431 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy alone (arm B)
Number of subjects: 168
Study 36066518 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized audit and feedback intervention (n=2933 GPs)
Number of subjects: 3660
Study 36066518 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention) (n=727 GPs)
Number of subjects: 3660
Study 35002817 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 37
Study 35002817 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 37
Study 35545343 — intervention group
Group type: EXPERIMENTAL
Intervention: IMB skills intervention
Number of subjects: 120
Study 35545343 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual health care)
Number of subjects: 120
Study 32573426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 0
Study 32573426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study 33491266 — intervention group
Group type: EXPERIMENTAL
Intervention: Trochlear dysplasia knees
Number of subjects: 121
Study 33491266 — intervention group
Group type: EXPERIMENTAL
Intervention: Female experimental group (Group FE)
Number of subjects: 121
Study 33491266 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-grade dysplasia group
Number of subjects: 121
Study 33491266 — intervention group
Group type: COMPARATOR
Intervention: Normal knees (Control group)
Number of subjects: 121
Study 32247676 — intervention group
Group type: EXPERIMENTAL
Intervention: VIP protocol (dilute povidone-iodine lavage followed by application of vancomycin powder)
Number of subjects: 1413
Study 32247676 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (not treated with VIP)
Number of subjects: 1413
Study 32247676 — intervention group
Group type: EXPERIMENTAL
Intervention: VIP protocol
Number of subjects: 1413
Study 34369975 — intervention group
Group type: EXPERIMENTAL
Intervention: Smell and taste of milk with tube feeding
Number of subjects: 396
Study 34369975 — intervention group
Group type: COMPARATOR
Intervention: Routine care without the provision of smell and taste of milk
Number of subjects: 396
Study 32560938 — intervention group
Group type: EXPERIMENTAL
Intervention: dCBT‐I
Number of subjects: 358
Study 32560938 — intervention group
Group type: COMPARATOR
Intervention: Control (online sleep education)
Number of subjects: 358
Study 34415434 — intervention group
Group type: EXPERIMENTAL
Intervention: Chairside-fabricated ZLS restorations with MMT 0.5-0.74 mm (group 1)
Number of subjects: 45
Study 34415434 — intervention group
Group type: EXPERIMENTAL
Intervention: Chairside-fabricated ZLS restorations with MMT 0.75-1.0 mm (group 2)
Number of subjects: 45
Study 34415434 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial crowns placed on premolars
Number of subjects: 45
Study 34415434 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial crowns placed on molars
Number of subjects: 45
Study 34415434 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive cement (SAC)
Number of subjects: 45
Study 34415434 — intervention group
Group type: COMPARATOR
Intervention: Restorations in group 2 (MMT 0.75-1.0 mm)
Number of subjects: 45
Study 34415434 — intervention group
Group type: COMPARATOR
Intervention: Molar partial crowns
Number of subjects: 45
Study 33693735 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-based protein food sources (beef sirloin, pork loin, eggs)
Number of subjects: 56
Study 33693735 — intervention group
Group type: COMPARATOR
Intervention: Plant-based protein food sources (tofu, kidney beans, peanut butter, mixed nuts)
Number of subjects: 56
Study 33693735 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal protein sources (egg and pork)
Number of subjects: 56
Study 33693735 — intervention group
Group type: EXPERIMENTAL
Intervention: All animal protein sources
Number of subjects: 56
Study 32770482 — intervention group
Group type: EXPERIMENTAL
Intervention: Human astrovirus (HAstV) infection
Number of subjects: 331
Study 36044915 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNB with MOSE
Number of subjects: 370
Study 36044915 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNB with standard technique
Number of subjects: 370
Study 34425258 — intervention group
Group type: EXPERIMENTAL
Intervention: TSO 1000
Number of subjects: 12
Study 34425258 — intervention group
Group type: EXPERIMENTAL
Intervention: TSO 2500
Number of subjects: 12
Study 34425258 — intervention group
Group type: EXPERIMENTAL
Intervention: TSO 7500
Number of subjects: 12
Study 34425258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34970772 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted survival benefit (RSB)
Number of subjects: 0
Study 34970772 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazard ratio
Number of subjects: 0
Study 34970772 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference of the restricted mean survival times
Number of subjects: 0
Study 34970772 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference in survival proportions at some fixed follow‐up time
Number of subjects: 0
Study 34970772 — intervention group
Group type: EXPERIMENTAL
Intervention: Net chance of a longer survival
Number of subjects: 0
Study 34175857 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.3 mg/kg
Number of subjects: 132
Study 34175857 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 0.3 mg/kg
Number of subjects: 132
Study 34175857 — intervention group
Group type: COMPARATOR
Intervention: Honey (placebo)
Number of subjects: 132
Study 34175857 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (melatonin, midazolam, placebo)
Number of subjects: 132
Study 33065218 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS e.max CAD crowns
Number of subjects: 15
Study 33065218 — intervention group
Group type: COMPARATOR
Intervention: IPS e.max Ceram hand-veneered zirconia crowns
Number of subjects: 15
Study 34735198 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 32
Study 34735198 — intervention group
Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 32
Study 32885344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive community care service (ICCS)
Number of subjects: 106
Study 32885344 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 106
Study 33156128 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG) surface-treated scleral lenses
Number of subjects: 21
Study 33156128 — intervention group
Group type: COMPARATOR
Intervention: Untreated scleral lenses
Number of subjects: 21
Study 32375843 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing interventions (group B)
Number of subjects: 90
Study 32375843 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (group A)
Number of subjects: 90
Study 36349701 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg subcutaneously
Number of subjects: 68
Study 36349701 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 68
Study 34643736 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach Avoidance Training (AAT)
Number of subjects: 28
Study 34643736 — intervention group
Group type: COMPARATOR
Intervention: Control procedure
Number of subjects: 28
Study 33768310 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% sorghum + 20% DM pumpkin
Number of subjects: 2
Study 33768310 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% sorghum + 40% DM pumpkin
Number of subjects: 2
Study 33768310 — intervention group
Group type: COMPARATOR
Intervention: 100% sorghum
Number of subjects: 2